How does metformin lower blood sugar
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
How Metformin Lowers Blood Sugar
Metformin is a widely used medication for managing type 2 diabetes mellitus (T2DM). Despite its long history, the precise mechanisms by which it lowers blood sugar are complex and multifaceted. This article synthesizes current research to elucidate how metformin achieves its glucose-lowering effects.
Inhibition of Hepatic Glucose Production
One of the primary mechanisms by which metformin lowers blood sugar is through the inhibition of hepatic glucose production (HGP). Metformin reduces fasting plasma glucose levels by suppressing accelerated basal HGP, likely through the inhibition of hepatic glycogenolysis. This effect is mediated by the activation of AMP-activated protein kinase (AMPK) in the liver, which plays a crucial role in cellular energy homeostasis . However, the role of AMPK has been questioned, and other mechanisms such as inhibition of mitochondrial glycerophosphate dehydrogenase have also been proposed .
Role of the Gastrointestinal Tract
Recent studies highlight the significant role of the gastrointestinal tract in metformin's glucose-lowering action. Metformin increases the secretion of the incretin hormone glucagon-like peptide 1 (GLP-1), which enhances insulin secretion and lowers blood glucose levels . This effect is partly due to metformin's ability to reduce intestinal bile acid resorption, thereby increasing intraluminal bile acids that stimulate GLP-1 secretion. Additionally, metformin's impact on the gut microbiota composition further contributes to its glucose-lowering effects.
First-Pass Pharmacodynamic Effect
Metformin exhibits a significant "first-pass" pharmacodynamic effect, meaning that its glucose-lowering action is more pronounced when administered orally compared to intravenous routes. This effect is attributed to the drug's action in the presystemic sites of the liver and gastrointestinal wall, which are critical for its overall glucose-lowering response.
Peripheral Insulin Sensitivity
Metformin also improves peripheral insulin sensitivity, although this is not its primary mechanism. By enhancing the body's response to insulin, metformin helps to lower blood glucose levels more effectively. However, studies have shown that metformin does not significantly enhance total body glucose disposal during insulin stimulation.
Modulation of Cellular Energy and Redox State
At the cellular level, metformin inhibits mitochondrial respiratory chain complex 1, leading to changes in cellular energy charge and redox state. This inhibition contributes to the suppression of hepatic gluconeogenesis, further lowering blood glucose levels .
Conclusion
Metformin lowers blood sugar through a combination of mechanisms, including the inhibition of hepatic glucose production, modulation of the gastrointestinal tract, and improvement of peripheral insulin sensitivity. Its multifaceted actions make it a highly effective and widely prescribed medication for managing type 2 diabetes. Understanding these mechanisms provides valuable insights into optimizing its use and exploring new therapeutic applications.
Sources and full results
Most relevant research papers on this topic